Pik3ca-related overgrowth spectrum (pros) Clinical Trials
Conditions / Pik3ca-related overgrowth spectrum (pros)
Delta Trials records 7 clinical trials for Pik3ca-related overgrowth spectrum (pros) in its publicly accessible dataset. From the full dataset, 3 actively seeking eligible participants and 2 trials have reached completion. This research is conducted across 69 study locations around the world. An additional 2 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
7
Total Trials
3
Recruiting
2
Completed
2
Other Active
0
Terminated since 2020
69
Study Locations
Browse by location (69 total)
- Madrid, Spain 5 trialsAll trials in Madrid, Spain
- Dijon, France 4 trialsAll trials in Dijon, France
- Paris, France 4 trialsAll trials in Paris, France
- Paris, France 4 trialsAll trials in Paris, France
- Montpellier, France 3 trialsAll trials in Montpellier, France
- Montpellier, France 3 trialsAll trials in Montpellier, France
- Roma, Italy 3 trialsAll trials in Roma, Italy
- St. Louis, United States 3 trialsAll trials in St. Louis, United States
- St. Louis, United States 3 trialsAll trials in St. Louis, United States
- Cincinnati, United States 3 trialsAll trials in Cincinnati, United States
- Boston, United States 3 trialsAll trials in Boston, United States
- Torino, Italy 2 trialsAll trials in Torino, Italy
- San Francisco, United States 2 trialsAll trials in San Francisco, United States
- Houston, United States 2 trialsAll trials in Houston, United States
- Esplugues, Spain 2 trialsAll trials in Esplugues, Spain
- Chapel Hill, United States 2 trialsAll trials in Chapel Hill, United States
- Tours, France 2 trialsAll trials in Tours, France
- London, United Kingdom 2 trialsAll trials in London, United Kingdom
- Leipzig, Germany 2 trialsAll trials in Leipzig, Germany
- Aurora, United States 2 trialsAll trials in Aurora, United States